Molecules / Doxazosin Mesilate

Doxazosin Mesilate API manufacturers

Updated 9 July 2026
7
manufacturers with an active filing 7 of them hold a US DMF or a CEP
2
shortage records on file across 1 countries
88
finished-dose makers across 3 regulators
Showing 7 of 7 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

Dr. Reddy's Laboratories

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for doxazosin mesilate, filing since 2025. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2025 · NAI
GMP recognised in
26 markets
How this listing is sourced EDQM certificate database
View profile
02

Excella Gmbh

Germany
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for doxazosin mesilate, filing since 2021. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 7 markets.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2022 · VAI
GMP recognised in
7 markets
How this listing is sourced EDQM certificate database
View profile
03

Nosch Labs

India
Makes the API

Holds one valid CEP for doxazosin mesilate, filing since 2025. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2024 · VAI
GMP recognised in
6 markets
How this listing is sourced EDQM certificate database
View profile
04

Cohance Lifesciences

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for doxazosin mesilate, filing since 2023. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2025 · NAI
GMP recognised in
1 markets
How this listing is sourced EDQM certificate database
View profile
05

Nifty Labs

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for doxazosin mesilate, filing since 2025. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2025 · VAI
GMP recognised in
1 markets
How this listing is sourced EDQM certificate database
View profile
07

Apitoria Pharma

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for doxazosin mesilate, filing since 2024.

US DMF
None on file
CEP
1 valid
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced EDQM certificate database
View profile

4 more manufacturers hold filings for doxazosin mesilate

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Cohance LifesciencesNifty LabsChemische Fabrik BergApitoria Pharma
Open the full list with a free account

Finished-dose makers (10)

Viatris United States Zentiva, k.s Czech Republic Bristol-Myers Squibb United States Laboratorios Cinfa S A Spain Laboratorios Normon Spain Towa Pharmaceutical Europe, S.L Spain Pt. Harsen Laboratories Indonesia Zaklady Farmaceutyczne Polpharma Poland Genus Pharmaceuticals United Kingdom Sandoz Switzerland

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Map doxazosin mesilate for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Also on this molecule

Shortages 2 Finished dose 10 Contract mfrs 0

By country

India 5